{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T17:44:50Z","timestamp":1770745490979,"version":"3.49.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,9,18]],"date-time":"2017-09-18T00:00:00Z","timestamp":1505692800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone Reports"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.bonr.2017.09.003","type":"journal-article","created":{"date-parts":[[2017,9,20]],"date-time":"2017-09-20T11:15:45Z","timestamp":1505906145000},"page":"108-113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Influence of gastrointestinal events on treatment of osteoporosis in Asia-Pacific women: Perspectives from physicians in the MUSIC OS-AP study"],"prefix":"10.1016","volume":"7","author":[{"given":"A.","family":"Modi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.R.","family":"Ebeling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.S.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.K.","family":"Min","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Mithal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Baidya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Sen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Sajjan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bonr.2017.09.003_bb0005","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/SMJ.0b013e31819ed0dd","article-title":"Improved gi tolerability with monthly ibandronate in women previously using weekly bisphosphonates","volume":"102","author":"Binkley","year":"2009","journal-title":"South. Med. J."},{"key":"10.1016\/j.bonr.2017.09.003_bb0010","first-page":"594","article-title":"Prevalence of functional gastrointestinal disorders in Taiwan: questionnaire-based survey for adults based on the Rome III criteria","volume":"21","author":"Chang","year":"2012","journal-title":"Asia Pac. J. Clin. Nutr."},{"key":"10.1016\/j.bonr.2017.09.003_bb0015","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s00198-006-0260-5","article-title":"Prevalence and predictors of osteoporosis treatment in nursing home residents with known osteoporosis or recent fracture","volume":"18","author":"Colon-Emeric","year":"2007","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bonr.2017.09.003_bb0020","doi-asserted-by":"crossref","first-page":"357","DOI":"10.2147\/CIA.S5637","article-title":"Gastrointestinal tolerability with ibandronate after previous weekly bisphosphonate treatment","volume":"4","author":"Derman","year":"2009","journal-title":"Clin. Interv. Aging"},{"key":"10.1016\/j.bonr.2017.09.003_bb0025","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1359\/jbmr.040905","article-title":"Osteoporosis prevalence and levels of treatment in primary care: the Australian Bonecare study","volume":"19","author":"Eisman","year":"2004","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bonr.2017.09.003_bb0030","doi-asserted-by":"crossref","first-page":"235","DOI":"10.5056\/jnm.2011.17.3.235","article-title":"Epidemiology of uninvestigated and functional dyspepsia in Asia: facts and fiction","volume":"17","author":"Ghoshal","year":"2011","journal-title":"J. Neurogastroenterol. Motil."},{"key":"10.1016\/j.bonr.2017.09.003_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/CIA.S97593","article-title":"Physicians' perspectives on the treatment of osteoporosis patients with bisphosphonates","volume":"11","author":"Gu","year":"2016","journal-title":"Clin. Interv. Aging"},{"key":"10.1016\/j.bonr.2017.09.003_bb0040","doi-asserted-by":"crossref","first-page":"143","DOI":"10.11005\/jbm.2014.21.2.143","article-title":"Physicians' attitudes to contemporary issues on osteoporosis management in Korea","volume":"21","author":"Ha","year":"2014","journal-title":"J. Bone Metab."},{"key":"10.1016\/j.bonr.2017.09.003_bb0045","first-page":"767","article-title":"Bones beyond 70\u2014insights into osteoporosis management in the elderly","volume":"39","author":"Inderjeeth","year":"2010","journal-title":"Aust. Fam. Physician"},{"key":"10.1016\/j.bonr.2017.09.003_bb0050","doi-asserted-by":"crossref","first-page":"325","DOI":"10.4140\/TCP.n.2011.325","article-title":"Reasons for bisphosphonate exclusion in patients treated for osteoporosis","volume":"26","author":"Kamneva","year":"2011","journal-title":"Consult. Pharm."},{"key":"10.1016\/j.bonr.2017.09.003_bb0055","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00198-012-2074-y","article-title":"European guidance for the diagnosis and management of osteoporosis in postmenopausal women","volume":"24","author":"Kanis","year":"2013","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bonr.2017.09.003_bb0060","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.bone.2012.02.007","article-title":"Prevalence, awareness, and treatment of osteoporosis among Korean women: the fourth Korea national health and nutrition examination survey","volume":"50","author":"Kim","year":"2012","journal-title":"Bone"},{"key":"10.1016\/j.bonr.2017.09.003_bb0065","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s11657-012-0097-9","article-title":"Endocrine, metabolic society of S. osteoporosis management and the utilization of Frax(r): a survey amongst health care professionals of the Asia-Pacific","volume":"7","author":"Korthoewer","year":"2012","journal-title":"Arch. Osteoporos."},{"key":"10.1016\/j.bonr.2017.09.003_bb0070","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1472-6874-13-7","article-title":"Factors influencing diagnosis and treatment of osteoporosis after a fragility fracture among postmenopausal women in Asian countries: a retrospective study","volume":"13","author":"Kung","year":"2013","journal-title":"BMC Womens Health"},{"key":"10.1016\/j.bonr.2017.09.003_bb0075","doi-asserted-by":"crossref","first-page":"56","DOI":"10.4055\/cios.2014.6.1.56","article-title":"Influence of insurance benefit criteria on the administration rate of osteoporosis drugs in postmenopausal females","volume":"6","author":"Lee","year":"2014","journal-title":"Clin. Orthop. Surg."},{"key":"10.1016\/j.bonr.2017.09.003_bb0080","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1445-5994.2008.01872.x","article-title":"Barriers to the implementation of evidence in osteoporosis treatment in hip fracture","volume":"39","author":"Levinson","year":"2009","journal-title":"Intern. Med. J."},{"key":"10.1016\/j.bonr.2017.09.003_bb0085","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11657-016-0272-5","article-title":"Patient-reported barriers to osteoporosis therapy","volume":"11","author":"Lindsay","year":"2016","journal-title":"Arch. Osteoporos."},{"key":"10.1016\/j.bonr.2017.09.003_bb0090","first-page":"107","article-title":"Clinical practice guidelines on postmenopausal osteoporosis: an executive summary and recommendations","volume":"4","author":"Meeta","year":"2013","journal-title":"J. Midlife Health"},{"key":"10.1016\/j.bonr.2017.09.003_bb0095","doi-asserted-by":"crossref","first-page":"449","DOI":"10.4103\/2230-8210.137485","article-title":"The asia-pacific regional audit-epidemiology, costs, and burden of osteoporosis in India 2013: a report of international osteoporosis foundation","volume":"18","author":"Mithal","year":"2014","journal-title":"Indian J. Endocrinol. Metab."},{"key":"10.1016\/j.bonr.2017.09.003_bb0100","doi-asserted-by":"crossref","first-page":"603","DOI":"10.2147\/CEOR.S83227","article-title":"Gastrointestinal events and association with initiation of treatment for osteoporosis","volume":"7","author":"Modi","year":"2015","journal-title":"Clinicoecon. Outcomes Res."},{"key":"10.1016\/j.bonr.2017.09.003_bb0105","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.bonr.2015.09.002","volume":"3","author":"Modi","year":"2015","journal-title":"Bone Rep."},{"key":"10.1016\/j.bonr.2017.09.003_bb0110","doi-asserted-by":"crossref","first-page":"694","DOI":"10.3904\/kjim.2013.28.6.694","article-title":"Endoscopic comparison of alendronate alone and the enteric-coated alendronate with calcitriol combination in postmenopausal Korean females","volume":"28","author":"Mok","year":"2013","journal-title":"Kor. J. Intern. Med."},{"key":"10.1016\/j.bonr.2017.09.003_bb0115","series-title":"Clinician's Guide to Prevention and Treatment of Osteoporosis","author":"National Osteoporosis Foundation","year":"2014"},{"key":"10.1016\/j.bonr.2017.09.003_bb0120","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00774-011-0326-0","article-title":"Osteoporosis patient treatment satisfaction questionnaire in postmenopausal women intermittently treated with oral bisphosphonates: the bravo study","volume":"30","author":"Oh","year":"2012","journal-title":"J. Bone Miner. Metab."},{"key":"10.1016\/j.bonr.2017.09.003_bb0125","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1007\/s00198-014-2647-z","article-title":"Alendronate, a bisphosphonate, increased upper and lower gastrointestinal bleeding: risk factor analysis from a nationwide population-based study","volume":"25","author":"Peng","year":"2014","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bonr.2017.09.003_bb0130","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-230X-8-5","article-title":"Epidemiology of constipation in Europe and Oceania: a systematic review","volume":"8","author":"Peppas","year":"2008","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.bonr.2017.09.003_bb0135","author":"Royal Australian College of General Practitioners"},{"key":"10.1016\/j.bonr.2017.09.003_bb0140","author":"Osteoporosis Association"},{"key":"10.1016\/j.bonr.2017.09.003_bb0145","first-page":"821","article-title":"Reasons for not initiating osteoporosis therapy among a managed care population","volume":"9","author":"Yu","year":"2015","journal-title":"Patient Prefer Adherence"}],"container-title":["Bone Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352187217300281?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352187217300281?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T16:16:24Z","timestamp":1762445784000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352187217300281"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":29,"alternative-id":["S2352187217300281"],"URL":"https:\/\/doi.org\/10.1016\/j.bonr.2017.09.003","relation":{},"ISSN":["2352-1872"],"issn-type":[{"value":"2352-1872","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Influence of gastrointestinal events on treatment of osteoporosis in Asia-Pacific women: Perspectives from physicians in the MUSIC OS-AP study","name":"articletitle","label":"Article Title"},{"value":"Bone Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bonr.2017.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Merck Sharp & Dohme Corp. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}